Author:
De Roock Wendy,Biesmans Bart,De Schutter Jef,Tejpar Sabine
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine,General Medicine
Reference79 articles.
1. Links M, Brown R. Clinical relevance of the molecular mechanisms of resistance to anti-cancer drugs. Expert Rev Mol Med 1999 Oct 25; 1999: 1–21
2. Schrohl A, Holten-Andersen M, Sweep F, et al. Tumor markers from laboratory to clinical utility. Mol Cell Proteomics 2003; 2: 378–87
3. McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005; 97: 1180–4
4. Hayes DF, Bast RC, Desch CE, et al. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst 1996; 88: 1456–66
5. Kitano H. Cancer as a robust system: implications for anticancer therapy. Nat Rev Cancer 2004; 4(3): 227–35
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献